Equities
Health CareHealth Care Providers
  • Price (JPY)1,908.00
  • Today's Change-27.00 / -1.40%
  • Shares traded1.58m
  • 1 Year change+26.82%
  • Beta1.4445
Data delayed at least 15 minutes, as of Jul 03 2025 06:47 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year M3 Inc had net income fall -10.57% from 45.27bn to 40.49bn despite a 19.26% increase in revenues from 238.88bn to 284.90bn. An increase in the cost of goods sold as a percentage of sales from 41.17% to 45.82% was a component in the falling net income despite rising revenues.
Gross margin54.18%
Net profit margin15.56%
Operating margin22.10%
Return on assets8.27%
Return on equity11.09%
Return on investment10.15%
More ▼

Cash flow in JPYView more

In 2025, cash reserves at M3 Inc fell by 14.73bn. However, the company earned 51.74bn from its operations for a Cash Flow Margin of 18.16%. In addition the company used 39.15bn on investing activities and also paid 27.17bn in financing cash flows.
Cash flow per share83.17
Price/Cash flow per share23.24
Book value per share557.32
Tangible book value per share253.18
More ▼

Balance sheet in JPYView more

M3 Inc has a Debt to Total Capital ratio of 11.08%, a higher figure than the previous year's 7.48%.
Current ratio2.96
Quick ratio2.92
Total debt/total equity0.1359
Total debt/total capital0.1108
More ▼

Growth rates in JPY

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -10.52%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)0.46%
Div growth rate (5 year)19.83%
Payout ratio (TTM)35.22%
EPS growth(5 years)13.34
EPS (TTM) vs
TTM 1 year ago
-10.59
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.